Under construction – not a live service
Sign in
Not yet taking people in PeruNo phase

Pilot Study of Essential Acute Stroke Care in Low-Resource Settings

Tests a package of basic acute stroke care in adults with stroke in low-resource settings.

Plain-language title generated from the registry record
Registry title: Essential Acute Stroke Care in Low Resource Settings: a Pilot studY

Key facts

Where
Piura, PeruSee the 2 sites

Where in Peru

  • Hospital de Apoyo II-2 SullanaPiura, PeruNo longer taking part
  • Hospital de la Amistad Peru Corea Santa Rosa II-2Piura, PeruNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
The George Institute
Trial code
NCT04157231
Record updated
11 June 2026
Original description
An investigator-initiated, evaluator-blinded, prospective, multi centre, before-and-after, effectiveness-implementation hybrid design study to assess the feasibility of essential acute stroke care in a low resource settingRead full original descriptionShow less

Essential Acute Stroke Care in Low Resource Settings: a Pilot Study

An investigator-initiated, evaluator-blinded, prospective, multi centre, before-and-after, effectiveness-implementation hybrid design study to assess the feasibility of essential acute stroke care in a low resource setting

Inclusion: Adults (age ≥18 years); A clinical or imaging-based diagnosis of acute stroke (ischemic or haemorrhagic) within 72 hours of stroke symptom onset; Provision of written informed consent; Subjects in observational, natural history and/or epidemiological studies not involving an intervention are eligible.

Exclusion: Subarachnoid haemorrhage; Patients who have undergone intravenous thrombolysis or mechanical thrombectomy; Patients who are planned for transfer to the intensive care unit; Participation in an interventional medical investigation or clinical trial currently or within the past 3 months.

ClinicalTrials.gov NCT04157231